ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesB51.8

B51.8

Leishmaniasis, other specified

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 B51.8 is a billable code used to indicate a diagnosis of leishmaniasis, other specified.

Key Diagnostic Point:

Leishmaniasis is a parasitic disease caused by protozoa of the genus Leishmania, transmitted through the bite of infected sandflies. The condition manifests in various forms, including cutaneous, mucocutaneous, and visceral leishmaniasis. The 'other specified' designation under code B51.8 indicates cases that do not fit neatly into the more common classifications of leishmaniasis, such as those caused by less prevalent species or atypical presentations. Clinically, leishmaniasis can present with skin lesions, fever, weight loss, and splenomegaly, depending on the form of the disease. Diagnosis typically involves clinical evaluation, serological tests, and sometimes biopsy of lesions. Treatment varies based on the species involved and the severity of the disease, with options including antimonial compounds, amphotericin B, and miltefosine. The emergence of antimalarial resistance in related parasitic infections highlights the importance of accurate species identification and tailored treatment strategies.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variety of species causing leishmaniasis
  • Differential diagnosis with other parasitic infections
  • Variability in clinical presentation
  • Need for specific laboratory confirmation

Audit Risk Factors

  • Inadequate documentation of species identification
  • Failure to specify the form of leishmaniasis
  • Misclassification with other parasitic diseases
  • Lack of supporting lab results

Specialty Focus

Medical Specialties

Infectious Disease

Documentation Requirements

Detailed clinical history, laboratory results, and treatment plans.

Common Clinical Scenarios

Patients presenting with skin lesions or systemic symptoms after travel to endemic areas.

Billing Considerations

Consideration of co-infections and travel history is crucial for accurate coding.

Dermatology

Documentation Requirements

Photographic evidence of lesions, biopsy results, and treatment response.

Common Clinical Scenarios

Patients with cutaneous leishmaniasis presenting with ulcerative skin lesions.

Billing Considerations

Documentation should clearly differentiate leishmaniasis from other dermatological conditions.

Coding Guidelines

Inclusion Criteria

Use B51.8 When
  • Follow the official ICD
  • CM coding guidelines, ensuring accurate documentation of the specific type of leishmaniasis and any associated conditions
  • Include laboratory confirmation when available

Exclusion Criteria

Do NOT use B51.8 When
No specific exclusions found.

Related CPT Codes

88305CPT Code

Pathology examination of tissue

Clinical Scenario

Used when biopsy of leishmaniasis lesions is performed.

Documentation Requirements

Pathology report and clinical notes detailing the lesion.

Specialty Considerations

Infectious disease specialists should ensure accurate coding of pathology results.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of leishmaniasis, improving data accuracy and facilitating better tracking of disease patterns and treatment outcomes.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of leishmaniasis, improving data accuracy and facilitating better tracking of disease patterns and treatment outcomes.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of leishmaniasis, improving data accuracy and facilitating better tracking of disease patterns and treatment outcomes.

Resources

Clinical References

  • •
    CDC - Leishmaniasis

Coding & Billing References

  • •
    CDC - Leishmaniasis

Frequently Asked Questions

What is the significance of specifying the type of leishmaniasis?

Specifying the type of leishmaniasis is crucial for determining the appropriate treatment and understanding the disease's epidemiology. Different species may have varying resistance patterns and clinical presentations.